INTRODUCTION
Two major classes of lipid mediators, glycerol phospholipid metabolites and sphingolipid metabolites, have been implicated in various cellular signaling events. Increasing evidence has shown the interaction or "cross-talk" among the signaling pathways mediated by these two classes of lipid mediators [1, 2] . PLA 2 2 is a kind of important and vastly diversified lipase in various species and organisms, which catalyzes the hydrolysis of sn-2 fatty acyl bonds of phospholipids [3] . Hydrolysis of phospholipids by PLA 2 generates arachidonic acid and lysophospholipids, which are important lipid signaling molecules or the precursors for the synthesis of other bioactive lipid mediators. The function of the sPLA 2 may result from its direct effect by hydrolysis of membrane phospholipids and from its indirect effect by liberation of bioactive lipid signaling molecules or their precursors. Snake venom is known as one of the richest sources of sPLA 2 and contains several types of sPLA 2 that are structurally homologous to the type II sPLA 2 found in mammalian species and contribute to some physiological and pathological effects of the venom [3, 4] . The synthesis and metabolic conversion of sphingolipids induced by intracellular and extracellular stimuli generate different sphingolipid signaling molecules that play important roles in the regulation of various biological processes. The sphingomyelin (SM) cycle has been known as a major pathway for sphingolipid metabolism that leads to the production of intracellular second messenger ceramide [5] . Evidence for the modulation of the activity of PLA 2 by SM, cholesterol, and annexin VI [6, 7] , which can change membrane susceptibility to PLA 2 or competitively inhibit PLA 2 , has been reported in recent years. TNF-␣-stimulated arachidonic acid liberation reportedly preceded ceramide generation, and arachidonic acid was shown to have an effect on TNF-␣-induced SM hydrolysis catalyzed by SMase in HL-60 and L929 cells, suggesting that PLA 2 plays a role in TNF-␣-induced ceramide generation [8, 9] . It was reported that EGF receptor phosphorylationdependent activity was coordinated with cytosolic phospholipase A 2 activation [10, 11] . A corresponding increase in cyclooxygenase activity upon EGF receptor activation has also been reported [12, 13] . Some type II PLA 2 isoforms have a unique tissue distribution, for example, in mouse small intestines and Paneth cells. They are reportedly involved in the enhancement of EGF receptor-mediated signaling and were therefore named enhancing factors [14 -16] . Enhancing factor can increase the binding of EGF to A-431 cells by first binding to its own cell surface receptor and then by creating a binding site for EGF. Moreover, mutations of the phospholipase activity site of enhancing factor retain enhancing factor activity, which indicates that enhancing factor activity and PLA 2 activity are two independent activities [17] , whereas another kind of PLA 2 isolated from the venom of Crotalus durissus terrificus, crotoxin (CT), was effective in stimulating tyrosine phosphorylation of the EGF receptor in cellular membranes of A-431 in vitro, which requires its PLA 2 activity, and no evidence for direct binding of CT to EGF receptor was found [18] .
The levels of ceramide, sphingosine, and sphingosine-1-phosphate, whose changes play important roles in intercellular and intracellular signaling events, can be regulated by EGF in osteoblastic cells [19] . EGF has also been reported to inhibit ceramideinduced apoptosis and to reduce the ceramide levels in primary placental trophoblasts [20] . Conversely, treatment with N-acetylsphingosine (C 2 -ceramide) and Nhexanoylceramide (C 6 -ceramide) prevented EGF-induced tyrosine trans-phosphorylation of the receptor in two different cell lines (A-431 and EGF-T17 cells) overexpressing the human EGF receptor without affecting the ligand binding capacity of the receptor [21] , indicating that sphingolipid metabolites have regulatory effects on EGF receptor activity. One of the metabolic derivatives of ceramide, ganglioside, is able to function as a modulator of growth factor receptors which can inhibit epidermal growth factor-stimulated receptor autophosphorylation [22] . Under physiological conditions, N, N-dimethylsphingosine, another major ceramide catabolite, can strongly enhance the autophosphorylation of EGF receptor in the absence of EGF or other stimuli, which indicates that N, N-dimethylsphingosine acts as a stereo-specific enhancer for EGF receptor [23] .
Though it has been previously demonstrated that there are several types of sPLA 2 which showed a stimulatory role in EGF receptor activation, in the present study, we found that a basic sPLA 2 purified from snake venom has an inhibitory effect on the proliferation of A-431 cells, EGF-induced EGF receptor autophosphorylation, tyrosine phosphorylation of phospholipase C-␥ 1 , and the activation of PLD, which are associated with arachidonic acid release and subsequent intracellular ceramide formation. The effects of arachidonic acid, SMase, and C 2 -ceramide were also investigated and compared in this study. SMase activity assay. SMase activity was quantified as previously described [9, 24] with minor modifications. Cells cultured in 60-mm plates were lysed and scraped into ice-cold lysis buffer containing 20 mM Hepes (pH 7.4), 0.1% Triton X-100, 2 mM EDTA, 1 mM ATP, 10 g/ml of leupeptin, 10 g/ml of aprotinin, and 1 mM PMSF and then sheared three times with a 2-ml needle. After centrifugation at 14,000g for 10 min, the resulting supernatant and the purified sPLA 2 were assayed for SMase activity. Assay buffers for the three different SMase were as follows: (1) Extraction and characterization of lipids. Cells were incubated with reagents for the indicated time, the treatment was terminated, and the total lipids in the organic phase were extracted and then loaded onto TLC plates for analysis as previously described [25] .
MATERIALS AND METHODS
Immunoprecipitation and Western blotting. A-431 cells (80% confluence) cultured in 60-mm plates were incubated in 0.5% BSAcontaining DMEM for 24 h and then treated with EGF in the absence or the presence of sPLA 2 , arachidonic acid, C 2 -ceramide, or SMase as indicated and then lysed in 0.4 ml of ice-cold lysis buffer (50 mM Hepes, pH 7.4, 5 mM EDTA, 50 mM NaCl, 1% Triton X-100, 50 mM NaF, 1 mM Na 3 VO 4 , 10 mM Na 4 P 2 O 7 ⅐ 10H 2 O, 10 g/ml of aprotinin, 10 g/ml of leupeptin, and 1 mM PMSF) followed by shearing using a 2-ml needle three times. The lysates were centrifuged at 14,000g for 10 min. The supernatants were analyzed by Western blotting after SDS-PAGE (6%) or immunoprecipitated with antibody (1 g/ ml) and 50 l of slurry of 50% protein A Sepharose CL-4B beads on a rotator overnight at 4°C. The immunoprecipitated beads were washed with lysis buffer and phosphate-buffered saline (PBS) three times each. The immunoprecipitated proteins were separated by SDS-PAGE on 6% (for EGF receptor) or 8% (for PLC-␥ 1 ) polyacrylamide gels. Immunoblotting were then performed as described previously [25] . The proteins were transferred onto nitrocellulose membranes followed by blocking with 5% BSA in tris-buffered saline (TBS) containing 0.1% Tween 20 for 1 h at room temperature and subsequently incubated with the primary antibody (1:2000 dilution) overnight at 4°C. After washing for another 1 h at room temperature, the membrane was further incubated with a horseradish peroxidaseconjugated secondary antibody for 2 h and washed for 1 h. The immunoreactive bands were visualized by enhanced chemiluminescent reagents. The protein level was detected under the same conditions after striping the membrane.
Growth inhibition. Cells were grown in 35-mm plates in the presence of 10% FCS and then treated with sPLA 2 , C 2 -ceramide, or AG1478 as indicated. To label the cells, [ 3 H]thymidine (0.2 Ci/ml) was added during the last 4 h of incubation. The incubation was terminated by pouring off the medium and washing the cells with ice-cold PBS three times followed by adding 20% trichloroacetic acid (TCA). The plates were maintained on ice for 20 min and washed again with ice-cold deionized water three times. The acid-insoluble material was dissolved in lysis buffer (1% SDS, 0.2 N NaOH) and moved into scintillation vials, mixed with 2.5 vol of BCS. The DNAassociated 3 H-labeled radioactivity was determined by liquid scintillation spectrometry.
Statistical analysis. Results are presented as means Ϯ ranges or standard deviations (SD) for the number of experiments indicated. For statistical analysis, Student's t test was performed. Differences were considered significant at P Ͻ 0.05.
RESULTS
The Activity of Purified Basic sPLA 2 The purity and the enzymatic activity of sPLA 2 had been determined and characterized as described previously [26] . The sPLA 2 , which has an isoelectric point of 9.3, migrated as a homogeneous single band in isoelectric focusing electrophoresis. The enzymatic activity of sPLA 2 was evaluated by determining its effects on inducing arachidonic acid release in intact A-431 cells. Figure 1A shows that sPLA 2 induced a rapid increase in extracellular arachidonic acid, which peaked at 5 min after treatment. The main types of cellular SMase are acidic SMase, neutral Mg 2ϩ -dependent SMase, and Mg 2ϩ -independent SMase. All of them contribute to the hydrolysis of cellular sphingomyelin located in different cellular compartments and responding to specific stimuli. To exclude the possibility that purified sPLA 2 was contaminated with any kind of SMase, we detected all three kinds of SMase activities in the purified sPLA 2 . Compared with the intracellular SMase activity in A-431, purified sPLA 2 did not show any hydrolytic activity on SM in various reaction buffers (Fig. 1B) .
FIG. 1.
The activity of purified sPLA 2 . (A) A-431 cells were labeled with [ 3 H]AA overnight and then washed three times in serumfree medium following a 30-min incubation in 1.5 ml of serumstarved medium before addition of sPLA 2 (1 g/ml). The extracellular AA released was counted with a liquid scintillation counter. The average dpm for untreated controls was 14,666. (B) [ 14 C]Sphingomyelin was used as the substrate for determining whether any SMase contamination exists in purified sPLA 2 . The endogenous intracellular SMase activity in the lysates (containing 800 g/ml of proteins) from A-431 cells was used as a positive control and was compared with that of purified sPLA 2 (20 g/ml). The product [ 14 C]phosphocholine generated was determined by the methods described under Materials and Methods. The lysis buffer for preparing lysates and dissolving sPLA 2 was used here as an untreated control. The acidic, neutral plus Mg 2ϩ , and neutral without Mg 2ϩ reaction buffers were used to determine acidic and neutral Mg 2ϩ -dependent and -independent SMase activity, respectively. Data are the means Ϯ range of three independent experiments performed in duplicate or triplicate.
sPLA 2 and Arachidonic Acid Stimulate an Increase in Intracellular Ceramide Formation
Since the ceramide generation is important in cellular stress responses and in sPLA 2 -induced toxic effects, we first investigated the ceramide production in A-431 cells in response to sPLA 2 treatment. As shown in Fig.2A , incubating cells with sPLA 2 induced an increase in the formation of intracellular ceramide, which became evident after 1 h. Arachidonic acid, a hydrolytic product of sPLA 2 , also showed a stimulatory effect on ceramide generation in a dose-dependent manner (Fig. 2B) , whereas LPA, another major product of the enzymatic activity of sPLA 2 , showed no effect on the induction of ceramide generation in A-431 cells. This result is consistent with the report that TNF-␣-induced ceramide generation in HL-60 cells is mediated by increased arachidonic acid release [8] . To investigate the effect of sPLA 2 and ceramide on EGF receptor autophosphorylation, two different antibodies specific to phosphorylated tyrosine (PY20) and tyrosine (at residue 1173)-phosphorylated EGF receptor, respectively, were used to detect EGF receptor phosphorylation. In Fig. 3A , sPLA 2 Fig. 3B , AG1478 was used as a positive control for the inhibition on EGFR autophosphorylation since AG1478 has been widely used as a specific inhibitor of EGFR tyrosine kinase. Treatment of cells with exogenous arachidonic acid exhibits on effect similar to that induced by sPLA 2 or C 2 -ceramide. Exogenous SMase, which induces a large increase in intracellular ceramide formation by catalyzing the hydrolysis of SM, also significantly inhibits EGF-induced EGF receptor phosphorylation (Figs. 3D and  3E ). Figure 3F gives the statistical results of the inhibition on EGF receptor phosphorylation by C 2 -ceramid, SMase, AA, and sPLA 2 .
sPLA 2 and Ceramide Inhibit EGF-Induced Activation of PLD and PLC-␥ 1
The interaction between the glycerol phospholipid signaling pathways and the sphingolipid signaling pathways is implicated in many physiological and pathological events. It has been reported that treatment of cells with EGF also stimulates the activation of PLD [27] [28] [29] , which lead to increased production of phosphatidic acid, whose hydrolysis mediated by phosphatidic acid phosphatase in turn resulted in an increase in intracellular second messenger diacylglycerol. Since sPLA 2 induces ceramide generation and inhibits EGF receptor activation in A-431 cells, which may also result in the inhibition of PLD activity, we therefore investigated the effect of sPLA 2 on EGFinduced PLD activation. As shown in Fig. 4A , treatment of cells with sPLA 2 did inhibit EGF-induced PLD activation as determined by transphosphatidylation reaction. Treatment of cells with C 2 -ceramide or SMase 2 and AA inhibit EGF-induced EGFR tyrosine phosphorylation. A-431 cells were treated with sPLA 2 (1 g/ml) and AA (50 M) for 2 and 4 h; EGF (50 ng/ml) was added for the last 30 min of incubation. The tyrosine-phosphorylated EGFR was first immunoprecipitated by anti-EGFR antibody and then its tyrosine phosphorylation level detected by immunoblotting using PY20, a specific antibody against tyrosino-phosphorylated protein. (B) sPLA 2 and C 2 -ceramide inhibit EGFR tyrosine autophosphorylation at tyrosine 1173. A-431 cells were treated with sPLA 2 (1 g/ml) or C 2 -ceramide (10 M) for the indicated times; EGF (50 ng/ml) was added for the last 30 min of incubation. AG1478 (250 nM), a specific inhibitor for EGFR autophosphorylation, was added to cells 10 min before EGF treatment. (C) sPLA 2 and C 2 -ceramide inhibit EGFR tyrosine autophosphorylation at tyrosine 1173. A-431 cells were treated with sPLA 2 or C 2 -ceramide for 2 h at the indicated concentrations. EGF (50 ng/ml) was added for the last 30 min of incubation. (D) AA and SMase inhibit EGFR tyrosine autophosphorylation at tyrosine 1173. A-431 cells were treated with AA (50 M) or SMase (100 mU/ml) for the indicated times; EGF (50 ng/ml) was added for the last 30 min of incubation. (E) AA and SMase inhibit EGFR tyrosine autophosphorylation at tyrosine 1173. A-431 cells were treated with AA or SMase for 2 h at the indicated concentrations. EGF (50 ng/ml) was added for the last 30 min of incubation. (F) C 2 -ceramide, SMase, AA, and sPLA 2 inhibit EGFR autophosphorylation at tyrosine 1173. A-431 cells were treated with C 2 -ceramide (10 M), SMase (100 mU/ml), AA (50 M), or sPLA 2 (1 g/ml) for 90, 60, 120, and 120 min, respectively. EGF (50 ng/ml) was added for the last 30 min of incubation. Statistical data shown in (A), (B), and (F) are the means Ϯ SD of three independent experiments. Other data represent results of two or three independent experiments. **P Ͻ 0.01 versus EGF-stimulated cells. also significantly decreased the EGF-induced PLD activity in A-431 cells (Fig. 4B) , which further implied a relationship between sPLA 2 and ceramide. It is known that PLC-␥ 1 is one of the substrates of EGF receptor tyrosine kinase [30] . The fact that basic sPLA 2 inhibits EGF receptor activation also suggests that it may play a role on the regulation of PLC-␥ 1 activity. As shown in Fig. 5A , treatment of cells with sPLA 2 does inhibit EGF-induced activation of PLC-␥ 1 as measured by tyrosine phosphorylation of PLC-␥ 1 . A similar effect of C 2 -ceramide was also observed (Fig. 5B) . The evidence confirmed that sPLA 2 -mediated inhibition of EGF-induced activation of the EGF receptor results in alteration in receptor downstream signaling events.
sPLA 2 and Ceramide Inhibit the Serum-Induced Proliferation of A-431 Cells
Under normal culture conditions, serum induces proliferation and maintains relatively higher EGF receptor activation in A-431 cells. To investigate the possible physiological relevance of sPLA 2 -and ceramide-mediated inhibition of EGF receptor, we determined the effects of sPLA 2 and ceramide on cell proliferation by using a thymidine uptake assay. As shown in Figs. 6A and 6B, both sPLA 2 and C 2 -ceramide treatment lead to a time-and dose-dependent inhibition of cell proliferation. Moreover, AG1478, a specific inhibitor of EGFR tyrosine kinase, also has an inhibitory effect on the proliferation of A-431 cells (Figs. 6C and 6D ). These data demonstrated that sPLA 2 -and ceramide-mediated inhibition of EGF receptor is implicated in cell proliferation.
DISCUSSION
Purified basic sPLA 2 exhibited specific and high enzymatic activity as determined by measuring arachidonic acid release from intact A-431 cells. Treatment of A-431 cells with sPLA 2 caused an increased intracellular ceramide formation. It has been reported that treatment of HL-60 and L929 cells with tumor necrosis factor-␣ (TNF-␣) results in the release of arachidonic acid through activating cytosolic PLA 2 , followed by a prolonged accumulation of ceramide [8, 9] , but in Mv1Lu cells, no increase in intracellular ceramide level was observed in response to either arachidonic acid or LPA treatment [26] . In the present study, we found that treatment of A-431 cells with arachidonic acid stimulated a rise in the cellular ceramide level, whereas this effect does not hold for LPA, another major product of the enzymatic activity of sPLA 2 . This Several types of PLA 2 from different sources were reported to have an additional function in enhancing EGF receptor-transduced signal events and were thus called "enhancing factor" [14 -16] . Enhancing factor was first found in Paneth cells, which have been shown to be a type II PLA 2 . Enhancing factor is able to enhance the binding activity of EGF receptor to its ligand through binding activity to its own receptor, first in a phospholipase-independent manner [14] . Crotoxin, a snake venom sPLA 2 , has been reported to stimulate EGF receptor autophosphorylation in vitro, which depends on its lipase activity, but it has no binding capacity to EGF receptor [18] . Here we demonstrated that sPLA 2 , another kind of snake PLA 2 , also has a modulatory effect on EGF receptor activation. Unlike the reported effect of crotoxin, sPLA 2 inhibits EGFinduced EGF receptor autophosphorylation in A-431 cells. A similar effect was observed when cells were treated with arachidonic acid, suggesting that arachidonic acid, one of the direct enzymatic products of sPLA 2 , is involved in the inhibitory effect of sPLA 2 on EGF receptor. Regulation of the intracellular ceramide level has been implicated in signaling events in various stressinduced cellular responses and other biological processes [31] [32] [33] [34] . As an important mitogenic signal transducer, EGF receptor is also downregulated through various trafficking compartments, such as caveolae, clathrin-coated pits, and some endosome populations, before its degradation in lysosomes [35] . It has been shown that the phosphorylation of EGF receptor at Thr669 mediates the interaction of the receptor with a specific tyrosine kinase substrate, which is required for efficient ligand-induced internalization of the receptor [36] . Goldkorn et al. [37] cifically on threonine residues while decreasing its tyrosine phosphorylation via the generation of ceramide from sphingosine. Another report showed that ceramide can presumably induce EGF receptor phosphorylation on Thr669 in A-431 cells [38] . Phosphorylation and dephosphorylation of Thr669 of the EGF receptor may be related to the EGF receptor trafficking processes. Gallardo et al. [21] recently reported that ceramide prevented EGF-induced tyrosine phosphorylation activity of the receptor without affecting EGF binding ability. Furthermore, alterations in the level of ganglioside, a metabolite of ceramide, may result in different responses to EGF. The depletion of ganglioside by sialidase gene transfection appeared to increase EGF receptor autophosphorylation. The ceramide analog D-threo-1-phenyl-2-decannoylamino-3-morpholino-1-propanol ([D]-PDMP) that inhibits UDP-glucose-ceramide glucosyltransferase has been shown to increase EGF-induced EGF receptor autophosphorylation [22] . These reported findings indicate that ceramide and other sphingolipid derivatives play important but probably different roles in the modulation of EGF/EGF receptor signaling events. In this study, we found that treatment of cells with basic sPLA 2 , and exogenous ceramide analogues C 2 -ceramide and neutral SMase prior to EGF treatment decreased the autophosphorylation of the EGF receptor at tyrosine residue 1173. Tyr1173 in EGFR is considered one major tyrosine phosphorylation site that is an important site recognized by some signaling proteins containing Src homology 2 (SH 2 ) domains, such as the SH 2 -containing adaptor protein Shc [39] . In mutant EGF receptor-transfected NIH-3T3 cells, in which the five known tyrosine autophosphorylation sites (tyrosines 992, 1068, 1086, 1148, and 1173) were replaced with phenylalanine residues, EGF treatment failed to elicit an increase in phosphatidylinositol 3-kinase activity to stimulate hydrolysis of phosphoinositides or tyrosine phosphorylation of phospholipase C-␥ 1 [40] . In Chinese hamster ovary cells expressing comparable levels of control or mutant EGF receptor (Tyr to Phe at 1173), the ability of the mutant receptor to mediate cell growth was reduced, yet both receptors exhibited a similar affinity for EGF, which indicated that Tyr1173 acts as a competitive or alternate substrate for the EGF receptor and that this region of the molecule is important in modulating its maximal biological activity [41] . From the data above, it seems that ceramide plays an important role in the downregulation of EGF signaling through inhibiting EGF receptor tyrosine autophosphorylation and/or stimulating the Thr669 phosphorylation on the receptor.
SMase was reported to enhance the catalytic activity of sPLA 2 by damaging the membrane asymmetry [42] and changing the surface pressure of the membrane [43] . In our previous study we showed that sphingomyelin plays a critical role in the control of the activity of secretory PLA 2 through which sPLA 2 -mediated signal transduction may be modulated [26] . It has been shown recently that sphingomyelin can inhibit the activity of cPLA 2 , whereas ceramide or cholesterol can reactivate the activity of cPLA 2 [7, 44] . It has also been reported that ceramide inhibits PLD activity in vitro and in intact cells [45, 46] . These findings suggest a "cross-talk" between the glycerol phospholipid and sphingolipid signaling pathways. PLC-␥ 1 is the substrate of EGF receptor tyrosine kinase and can be rapidly tyrosine phosphorylated after EGF stimulation, which also depends on specific autophosphorylation on several tyrosine sites of EGF receptors [40] . Our data demonstrated that both basic sPLA 2 and ceramide are able to downregulate the EGF-induced tyrosine phosphorylation of PLC-␥ 1 , which is consistent with their inhibitory effects on EGFR autophosphorylation. The inhibition of EGF-induced receptor activation, PLD activity, and the tyrosine phosphorylation of PLC-␥ 1 in A-431 cells by ceramide and sPLA 2 indicate a complex interaction among the signaling events mediated by EGF receptor, PLD, PLC-␥, sPLA 2 , and ceramide. The evidences also suggest that ceramide mediated inhibition of EGF-induced PLD activity may be partially due to its inhibition of EGF receptor activation. Both basic sPLA 2 and ceramide could induce cell death in Mv1Lu cells [26] , but in A-431 cells, neither basic sPLA 2 nor C 2 -ceramide (at 10 M or below) induces obvious apoptosis. However, both basic sPLA 2 and C 2 -ceramide can inhibit the proliferation of A-431 cells as measured by DNA synthesis, which was also observed when cells were treated with the specific inhibitor of EGFR tyrosine kinase AG1478. These findings suggest that sPLA 2 and C 2 -ceramide-mediated inhibition of EGF receptors may be involved in the regulation of cell proliferation.
In summary, we demonstrated in this report that basic sPLA 2 purified from snake venom inhibits EGFinduced EGF receptor activation and the subsequent signaling events and stimulates the ceramide generation in A-431 cells. Exogenous arachidonic acid, C 2 -ceramide, and SMase showed the same effects, which also suggests that the biological roles of ceramide and arachidonic acid generated on cells are partially due to their effects on EGF receptor-mediated intracellular signaling events. The data may have potential important implications in understanding the modulation of EGF receptor signaling and the interactions among the signaling pathways mediated by some different bioactive lipid molecules.
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